“Some days I wake up and will’t think how far we’ve come,” stated Dr. Doblin, 67, who now oversees the Multidisciplinary Association for Psychedelic Scientific studies, a multimillion dollar investigate and advocacy empire that employs 130 neuroscientists, pharmacologists and regulatory professionals Doing work to put the groundwork for the